ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
I was pleased to read the article on nuclear medicine (C&EN, Sept. 7, 2009, page 58). I am a chemist as well as a nuclear medicine intern, so it was exciting to have my favorite chemistry magazine shine its light on my field.
The article gave an in-depth look at the problems my colleagues and I currently face due to the lack of a reactor in the U.S. dedicated to producing radioisotopes. Some weeks we have a steady supply of technetium-99m, which is our star player, but when the reactors go down, we have to turn to our second-string isotopes. They can be more cumbersome.
It was also exciting to be able to trace our technetium-99m isotope step-by-step and in great detail through the process all the way back to the reactor cell and radionuclide from which it originated.
I also enjoyed reading about the legislative action, alternatives to our radioisotope supply, and what the future may hold for isotope production. My compliments to the author for a great article.
Nick Bujouves
Ypsilanti, Mich.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X